Baricitinib Impurities and its Related Products



Displaying 18 results of Baricitinib Impurities

Baricitinib Impurities are the unwanted substances that are present in Baricitinib drug products. These impurities may be formed during the manufacturing process or may be introduced during the storage or handling of the drug product. The presence of these impurities can affect the efficacy and safety of the drug product, and therefore it is essential to monitor and control them. The regulatory authorities have set limits for these impurities, and drug manufacturers must comply with these limits to ensure the quality and safety of the drug product.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Acetamide Baricitinib Impurity Impurities CS-EO-01936 2271228-51-2 In Stock
Barcitinib Lactone Impurity Impurities CS-O-38670 2910813-43-1 Enquire
Baricitinib 3-Hydroxy Impurity Impurities CS-O-54068 Not Available Enquire
Baricitinib Acetic Acid Impurity Impurities CS-EO-01083 2271228-52-3 Enquire
Baricitinib Acid impurity Impurities CS-ED-02440 Not Available Enquire
Baricitinib Impurity 2 Impurities CS-O-34971 Not Available Enquire
Baricitinib Impurity 20 Impurities CS-EO-02241 Not Available Enquire
Baricitinib Impurity 21 Impurities CS-EO-02242 Not Available Enquire
Baricitinib Impurity 28 Impurities CS-O-40695 1187595-90-9 Enquire
Baricitinib Impurity 3 Impurities CS-P-08519 1187595-89-6 Enquire
Baricitinib Impurity 76 Impurities CS-O-59561 Not Available Enquire
Baricitinib Impurity 77 Impurities CS-O-59562 Not Available Enquire
Baricitinib impurity C Impurities CS-O-37771 2055723-13-0 In Stock
Baricitinib Impurity I Impurities CS-O-41919 Not Available Enquire
Baricitinib Methyl Ester Impurity Impurities CS-O-38524 2402776-80-9 Enquire
BRY-II Impurities CS-T-94277 1627504-43-1 Enquire
N-Desethylsulfonyl N-Propylsulfonyl Baricitinib Impurities CS-O-38525 1187594-34-8 Enquire
Pyrrolopyrimidine Baricitinib Impurities CS-O-38526 2910813-45-3 Enquire